Prevalence and Treatment of Urinary Incontinence in Women With Cystic Fibrosis and Chronic Obstructive Pulmonary Disease
Recruitment status was Active, not recruiting
- Full Text View
- Tabular View
- No Study Results Posted
- Disclaimer
- How to Read a Study Record
Purpose
Women with chronic lung disease characterised by chronic cough report urinary incontinence. Recently there have been reports of increased urinary incontinence in girls and women with cystic fibrosis. While coughing is a known risk factor for stress incontinence, other risk factors and causes are poorly understood in this population. Treatment of incontinence for patients with chronic lung disease is also poorly addressed, adding to the burden of disease for women with chronic lung disease, carers and the health system. This project will estimate the prevalence of women with CF and COPD compared to healthy age matched controls and will evaluate the effect of a specific treatment and management program for these patients. The results will be disseminated to respiratory health professionals. We hypothesise that women with chronic cough will have a higher incidence of urinary incontinence than healthy controls and that a specific treatment program will result in alleviation of the problems and improved quality of life.
| Condition | Intervention |
|---|---|
|
Cystic Fibrosis Chronic Obstructive Pulmonary Disease (COPD) |
Procedure: Pelvic floor muscle training, biofeedback, electrotherapy, bladder training |
| Study Type: | Interventional |
| Study Design: | Allocation: Non-Randomized Endpoint Classification: Efficacy Study Intervention Model: Factorial Assignment Masking: Open Label Primary Purpose: Treatment |
| Official Title: | Development of an Intervention and and Education Program for Adult Women With Urinary Incontinence and Chronic Lung Disease Including Cystic Fibrosis (CF) and Chronic Obstructive Pulmonary Disease (COPD) |
- Symptom measures:
- 3-day frequency volume chart,
- 24 hour pad weigh test,
- accident diary,
- quality of life using King's Health Questionnaire.
- pelvic floor muscle function:
- Trans-abdominal diagnostic ultra-sound
- EMG study of the pelvic floor muscles
| Estimated Enrollment: | 180 |
| Study Start Date: | December 2001 |
| Estimated Study Completion Date: | December 2006 |
Show Detailed Description Eligibility| Ages Eligible for Study: | 18 Years to 70 Years |
| Genders Eligible for Study: | Female |
| Accepts Healthy Volunteers: | Yes |
Inclusion Criteria:
- Women with CF and COPD
Exclusion Criteria:
-
Contacts and Locations| Australia, Victoria | |
| The Alfred Hospital | |
| Melbourne, Victoria, Australia, 3004 | |
| School of Physiotherapy, The University of Melbourne | |
| Melbourne, Victoria, Australia, 3052 | |
| Principal Investigator: | Brenda M Button, DPhty, PhD | The Alfred Hospital, Melbourne |
| Study Director: | John W Wilson, MBBS, PhD | The Alfred Hospital, Melbourne |
More Information
No publications provided
| ClinicalTrials.gov Identifier: | NCT00164138 History of Changes |
| Other Study ID Numbers: | 108/01, Dept. of Health and Aged Care |
| Study First Received: | September 13, 2005 |
| Last Updated: | October 17, 2006 |
| Health Authority: | Australia: National Health and Medical Research Council |
Keywords provided by Bayside Health:
|
Incontinence, physiotherapy, treatment, pelvic floor muscle function, coughing, forced expirations, lung disease |
Additional relevant MeSH terms:
|
Cystic Fibrosis Fibrosis Lung Diseases Respiration Disorders Pulmonary Disease, Chronic Obstructive Urinary Incontinence Lung Diseases, Obstructive Pancreatic Diseases Digestive System Diseases |
Respiratory Tract Diseases Genetic Diseases, Inborn Infant, Newborn, Diseases Pathologic Processes Urination Disorders Urologic Diseases Urological Manifestations Signs and Symptoms |
ClinicalTrials.gov processed this record on May 16, 2013